Trillium Therapeutics (Canada) a preclinical-stage biopharmaceutical company focused on interstitial cystitis, closed a $1M Series A financing. Participants include BDC Venture Capital.
Taris Biomedical (Lexington, MA) a preclinical-stage drug:device company focused on interstitial cystitis, close a $15M Series A financing. Participants include Flagship Ventures, Flybridge Capital Partners and Polaris Venture Partners.